ALK and adenocarcinoma: If the EGFR mutational status of an EBUS-GS specimen is negative, a false-negative should be considered when the sample volume is small, particularly if the patient is at risk of EGFR or ALK mutation (has an adenocarcinoma, is a female East Asian, or is a never-smoker) [36–39].